Integer (NYSE:ITGR) Insider Sells $2,496,341.25 in Stock

Integer Holdings Corporation (NYSE:ITGR) insider Kirk Thor sold 19,773 shares of the company’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $126.25, for a total transaction of $2,496,341.25. Following the transaction, the insider owned 18,920 shares of the company’s stock, valued at approximately $2,388,650. The trade was a 51.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Integer Stock Performance

NYSE ITGR opened at $126.35 on Friday. The company’s fifty day moving average is $117.59 and its two-hundred day moving average is $98.67. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $126.79. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. The firm has a market capitalization of $4.30 billion, a price-to-earnings ratio of 34.52, a P/E/G ratio of 2.40 and a beta of 0.62.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The business had revenue of $464.11 million during the quarter, compared to analyst estimates of $451.07 million. During the same quarter in the prior year, the business earned $1.55 earnings per share. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. Equities research analysts forecast that Integer Holdings Corporation will post 6.09 EPS for the current year.

Institutional Trading of Integer

Institutional investors have recently bought and sold shares of the stock. HBK Investments L P bought a new stake in Integer in the second quarter valued at $14,502,000. Sequoia Financial Advisors LLC lifted its holdings in shares of Integer by 4.7% during the second quarter. Sequoia Financial Advisors LLC now owns 3,180 shares of the medical equipment provider’s stock valued at $297,000 after acquiring an additional 142 shares during the period. Corient Private Wealth LP lifted its holdings in shares of Integer by 10.7% during the second quarter. Corient Private Wealth LP now owns 48,981 shares of the medical equipment provider’s stock valued at $4,577,000 after acquiring an additional 4,742 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Integer in the 2nd quarter valued at $215,000. Finally, Bluefin Capital Management LLC boosted its stake in shares of Integer by 263.6% in the 2nd quarter. Bluefin Capital Management LLC now owns 30,332 shares of the medical equipment provider’s stock valued at $2,835,000 after purchasing an additional 21,990 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ITGR shares. HC Wainwright reissued a “buy” rating on shares of Integer in a report on Friday, July 24th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a research report on Monday. KeyCorp downgraded shares of Integer from an “overweight” rating to a “sector weight” rating in a research note on Monday, August 3rd. Truist Financial lowered shares of Integer from a “buy” rating to a “hold” rating and boosted their price target for the company from $110.00 to $127.00 in a report on Monday, August 3rd. Finally, Citigroup increased their price objective on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. One research analyst has rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $109.86.

About Integer

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.